Search

everythinglearnresearchcommunity

for

Search:↓

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Sophora flavescens extract may help hair grow by affecting growth factors and blocking a hair-related enzyme.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

Androgens promote beard growth but cause hair loss in androgenetic alopecia, with TGF-β1 as a potential treatment target.

Chinese men have lower AGA rates than Caucasians, with type III vertex most common; family history is important.

A gene mutation in mice causes skin defects and early death.

Finasteride effectively reduces hair loss by decreasing androgen levels.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

MMP-19 may worsen skin diseases by affecting skin growth and inflammation.

Growth factors can either promote or inhibit hair follicle cell growth and collagen breakdown.

Testosterone boosts red blood cell production and changes iron metabolism without needing dihydrotestosterone.

Fibronectin and other basement membrane components increase during hair growth and decrease during rest.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

PCOS prevalence varies by ethnicity and location due to inconsistent diagnosis and limited research.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Stress keratins are expressed less in diseased skin and are linked to differentiation, inflammation, and immunity.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

The study found that the enzyme linked to acne is present in the same areas of both acne-affected and normal skin.

Porcine skin varies by region, affecting its use as a human skin model.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.